The mid-to-long-term vision that the company drew up in 2007, set the targets: ‘Establish a solid foundation for the domestic business’, ‘Expand the international business operation’ and ‘Enrich
Michael Fort, chief executive of Synexus, said: “Once again our model has been shown to deliver the right numbers of patients at the right time even when it
Under the agreement, Dstl has assigned all patent rights and know-how associated with the antimicrobial peptides for commercial use to Isogenica. Isogenica will exclusively market and distribute the
As per the agreement, Laboratorios Bago will distribute a variety of Stematix orthopedic and cellular products for use in regenerative and related medical treatments. The terms of the
The alliance allows a technology transfer from PharmaCore to Albemarle, offering PharmaCore customers long term, higher volume capacity for their pharmaceutical projects. Albemarle’s custom manufacturing capabilities include a
Stefan Verheye, department of cardiology at Middelheim Hospital, Antwerp, said: “These clinical results suggest very promising benefits for patients. We had already demonstrated that the self-expanding and disconnectable
Xerese (formerly Lipsovir, ME-609), used for topical treatment of herpes labialis (cold sores), contains a combination of the antiviral substance acyclovir and hydrocortisone. Xerese is the first topical
John Weinstein, principal investigator of the project, said: “L-ASP is a standard component of leukemia chemotherapy regimens, but it’s not used yet against solid tumors due to erratic
Leslie Hudson, president and CEO of AVI BioPharma, said: “AVI shares a commitment with the Foundation to Eradicate Duchenne and CureDuchenne to advance the research and development of
Reportedly, from February 15, ChemPoint is expected to be the national distributor within the US for industrial applications of Momentive’s Tospearl Micro-Fine silicone resins. ChemPoint will provide marketing,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.